CEO Sells $70K in Open Market Shares Amidst Delisting Concerns
CDLX is trading near its 52-week low of $4.25 (2.8% above the low).
Summary
Cardlytics CEO Amit Gupta sold $70,917 worth of common stock on the open market, a negative signal given the company's recent reverse split and Nasdaq delisting notice.
Key Events · Ownership and Investor Activity · CDLX
-
CEO Open Market Sale
CEO Amit Gupta sold 16,138 shares of common stock on the open market for a total value of $70,917. The sales occurred between July 2 and July 6, 2026, at an average price of approximately $4.39 per share.
-
RSU Vesting
The CEO also acquired 31,250 shares of common stock through the vesting of Restricted Stock Units (RSUs) on July 1, 2026. This is a routine compensation event.
-
Context of Distress
This sale follows a 1-for-10 reverse stock split on June 8, 2026, and a Nasdaq delisting notice received on June 3, 2026, due to failing to meet the minimum bid price. The stock is currently trading near its 52-week low.
Analysis · CDLX · Technology
CEO Amit Gupta sold shares on the open market for $70,917. This sale, occurring while the stock trades near its 52-week low and shortly after a reverse stock split and Nasdaq delisting notice, suggests a lack of confidence from top management during a critical period for the company. While the CEO also acquired shares through RSU vesting, the open market sale is a direct signal of disposition.
At the time of this filing, CDLX was trading at $4.37 on NASDAQ in the Technology sector, with a market capitalization of approximately $25.4M. The 52-week trading range was $4.25 to $32.80. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.